Corbus Pharmaceuticals Holdings, Inc., announced it will soon begin a Phase 2 clinical trial to test the efficacy, safety, tolerability, and biologic effects of its drug candidate, Resunab, in patients with systemic lupus erythematosus (SLE). Resunab is a first-in-class, synthetic oral endocannabinoid-mimetic drug that preferentially binds to the CB2 receptor expressed on activated…
Aurinia Pharmaceuticals recently announced the U.S. Food and Drug Administration (FDA) has granted Fast Track designation to voclosporin, a next-generation calcineurin inhibitor under development to treat patients with lupus nephritis (LN) and other autoimmune diseases. LN is a kidney inflammation caused by systemic lupus erythematosus (SLE) in which patients may develop proteinuria,…
Immunovia AB recently announced it has entered into a collaboration with a large multinational life science company to jointly conduct trials to expand the application of IMMray, a technology platform based on antibody microarray analysis, to include autoimmune diseases like systemic lupus erythematosus (SLE). The company was not otherwise…
The Lupus Foundation of America announced that its 2016 peer-reviewed research funding will include a focus on lupus studies into stem cells, environmental disease triggers, and outcomes in children and teenagers. Applications from researches are now being accepted for the awards, which can range up to $140,000. The foundation will…
How often should you exercise when you have lupus? Research has shown that lupus patients are strong believers in the benefits of exercise, but may not exercise enough over concerns of fatigue, overexposure to sunlight, and injury — legitimate concerns but ones less important than countering the disease’s impact on…
As a celebration for its 37th anniversary of independence, St. Lucia Arthritis and Lupus Association (SLALA) reflects on the journey so many people face by dealing with chronic diseases under the theme “The Journey Continues.” According to a press release, SLALA has created an opportunity for St. Lucians to find a way to…
Ulster University researchers found that mercury exposure through dental fillings or the consumption of seafood does not exacerbate symptoms of systemic lupus erythematous (SLE). While there is a lack of scientific evidence, exposure to mercury is widely believed to trigger SLE in patients who are genetically susceptible. In…
Temple University School of Medicine researchers have discovered how infections cause lupus flares. In a study funded by the Lupus Research Institute (LRI) and the NIH’s National Institute of Arthritis and Musculoskeletal and Skin Diseases (NIAMS), Stefania Galluci, PhD, and her team identified a mechanism through which a specific type…
Immunovia AB, together with Lund University in Sweden, will launch a new program to develop, validate, and commercialize antibody array-based tests for differential diagnostics and for prediction and monitoring of systemic lupus erythematosus (SLE) flares. SLE is one of the hardest diseases to diagnose as its symptoms are similar to those…
Systemic lupus erythematosus (SLE) patients with chronic renal failure who are using anticoagulants or antiepileptics are at higher risk for osteoporosis and fragility fractures, according to a study, “Risk factors for osteoporosis and fragility fractures in patients with systemic lupus erythematosus,” published in the journal Lupus Science…